CRISPR THERAPEUTICS AG Operating Leases, Future Minimum Payments, Due in Five Years
CRISPR THERAPEUTICS AG (CRSP) had Operating Leases, Future Minimum Payments, Due in Five Years of $5.86 million as of 2018-12-31, per its 10-K filed 2019-02-25.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2019-02-25
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $5.86M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $5.88M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $7.03M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $1.47M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2018-12-31 | $5.86M 10-K · filed 2019-02-25 |
| 2017-12-31 | $5.88M 10-K · filed 2018-03-08 |
| 2016-12-31 | $7.03M 10-K · filed 2017-03-10 |
| 2015-12-31 | $1.47M 10-Q · filed 2016-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |